retatrutide weight regain after stopping November Blog Retatrutide: A Triple Agonist Shaping

IeB Perspective: Underscoring the growing opportunities in addressing drug shortages and advancing complex generics with limited competition, pharma companies and CROs should focus on innovative peptide-based therapeutics, proactive regulatory engagement, and leveraging FDA programs like pre-ANDA for accelerated approvals

Its called Lumen, and its designed to help you understand what your metabolism is doing in real time, so you can tailor your food, training, and lifestyle to support your goals

Saguil A, Kane S, Mercado M, Lauters R

Your starting dose is determined by your provider based on your health profile, sensitivity, and goals

Starting with a low dose and increasing it slowly helps reduce these problems

And per commentary from Eli Lilly leadership, whose ads you probably saw 100,000 times during Olympics coverage, the tirzepatide GLP-1 shortage is coming to an end very soon. There are 50+ mentions of obesity and weight in Hims & Hers Q2 call